Haemonetics: Re-Rating Complete, Time To Cash In (NYSE:HAE)

If you like to see more ideas, please subscribe to the premium service "Value in Corporate Events" here and try the free trial. In this service we cover major earnings events, M&A, IPOs and other significant corporate events with actionable ideas. Furthermore, we provide coverage of situations and names on request!In August of last year, I concluded that blood had finally arrived in the streets after a tough time for shares of Haemonetics ( HAE ) . Shares plunged, even as the company maintained the full-yea ...